Meet the Team: Beatrix Szebeni-Varga
.png)
Beatrix has over 15 years of experience in Clinical Project Management
How to Switch to Zeffy for Donations
.png)
This zero-fee payment processor makes sure 100% of your donation reaches Foregen!
HistologiX: Assay Optimization
Critical Preparation for the Histology Study
Meet the Team: Luca Pennasilico
An interview with the PhD student assisting with our sheep trials
Sheep Trials Part 1: Preparing the Sheep and Attaching ECMs
.png)
A behind-the-scenes look into our sheep trials.
Meet Dr. Dan mon O'Dey
.png)
Foregen Consultations with Renowned Plastic and Reconstructive Surgeon in Germany
$26,390 Raised in Our Matching Campaign - Let's Keep the Momentum Going!
.png)
Over halfway there!
Double Your Impact: Foregen's $50,000 December Matching Campaign!
.png)
Let's end the Year on a High Note!
$22,500 Raised for GoFundMe Campaign!
.png)
A huge THANK YOU to everyone who has supported us.
The Pievesestina Skin Bank Receives Approval for an Important Patent for the Preservation of Tissues at Room Temperature
Longer storage times allowed for clinical use. The inventors are Dr. Elena Bondioli, Professor Davide Melandri, and Dr. Valeria Purpura.
Two Recent Achievements: $15,000 Fundraiser Update & Exciting Research News!
.png)
A Fundraising Milestone and New Results from Dr. Riccio's Cadaver Lab Work
Join Foregen's September Surge: Finishing Sheep Trials
.png)
Discover the remarkable progress of our sheep trials and how your support in our September Fundraiser can make history in regenerative medicine.
Sheep Trials: Successful Blood Vessel Formation and Scaffold Colonization
.png)
"It's a Fantastic Thing"
A New Era for Foregen
.png)
Improved Governance Structure
Year in Review: 2022
Looking Back
Stakeholder Report #2: Sheep Trials
Animal Trials
5 Million Men? More Than Triple That: Over 18 Million American Men Would Consider Regenerating Their Foreskin.
YouGov Survey
Sheep Trial Stakeholder Report
Updates
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 4)
Animal Model
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 3)
Animal Model
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 2)
Animal Model
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 1)
Animal Model
Rat Model Overview
Animal Trials
A Year in Review: 2021
Looking Back
Human Clinical Trial Clarification
Questions Answered
Foregen's Human Clinical Trial
General Overview and Planned Dates
YouTube Livestream Event!
$1 million Donation Mark
December $100,000 Matching Campaign
Looking to the Future
Tax Benefits of Crypto Donations to Foregen
End of Year Giving
What's a Histology Study?
A Foregen Discussion
Ahiṃsā: The Sanctity of Life
Compassion in Buddhism
Weekly Recap October 16th, 2021
ICYMI
A Bridge to Heal America: How Glans Restoration Restores Immune Protection
Foreskin Benefits
YouGov Survey 2021
New Data
Weekly Recap September 24th, 2021
ICYMI
Weekly Recap September 17th, 2021
ICYMI
Animal Trial Update
Current Research
Weekly Recap September 10th
ICYMI
Letter to Discover Magazine
Ethical Considerations
Foreskin Arterial Endothelial Glycocalyx Essential for Organ Development, Function and Resilience.
The Glycocalyx
Penile Vascular Tissue Removal Reduces Organ Capacity for Erection
The Importance of the Vascular Endothelium
A Push Beyond Africa
The VMMC Campaigns Go Global
The Fallout of Misguided Circumcision Campaigns in Sub-Saharan Africa
Circumcision in Africa
International Contractors are Profiteering from New Circumcision Devices
Circumcision in Africa
Circumcision Stakeholders in Africa
Crucial Dissent Went Unreported
Is Circumcision a Fraud?
The Fast Facts
Animal Model Blog
Breakdown
Website Refresh
New Design
COVID-19 Update
Announcement
